Dreyfus Andrew
SEC CIK 1670893 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IRWD | IRONWOOD PHARMACEUTICALS INC | Dir | 228.3K | — | — | 6 | 2021-09-15 | 2025-06-10 |
Most active insiders at IRWD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | DENNER ALEXANDER J | Dir, 10% | — | $20.53M |
| 2 | Silver Ronald | Principal Accounting Off | — | $831.2K |
| 3 | MCCOURT Thomas A | CEO, Dir | — | $739.9K |
| 4 | John Minardo | CLO | — | $136.2K |
| 5 | Gaskins Tammi L | Chief Commercial Off | — | $100.3K |
| 6 | Martini Gregory S. | CFO | — | $81.9K |
| 7 | McHugh Julie | Dir | — | $80.5K |
| 8 | Silber Jeffrey | SVP, CMO, Head-Res, Drug | — | — |
| 9 | Moukheibir Catherine | Dir | — | — |
| 10 | Duane Jon R | Dir | — | — |
Dreyfus Andrew made no open-market trades at IRWD in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-12 | 2025-06-10 | IRWD | IRONWOOD PHARMACEUTICALS INC | Dreyfus Andrew | Dir | A - Grant | $0.00 | +45.0K | 228.3K | +25% | $0 | |
| 2024-06-21 | 2024-06-18 | IRWD | IRONWOOD PHARMACEUTICALS INC | Dreyfus Andrew | Dir | A - Grant | $0.00 | +24.3K | 188.2K | +15% | $0 | |
| 2023-06-22 | 2023-06-20 | IRWD | IRONWOOD PHARMACEUTICALS INC | Dreyfus Andrew | Dir | A - Grant | $0.00 | +22.4K | 169.0K | +15% | $0 | |
| 2022-06-03 | 2022-06-01 | IRWD | IRONWOOD PHARMACEUTICALS INC | Dreyfus Andrew | Dir | A - Grant | $0.00 | +21.6K | 151.6K | +17% | $0 | |
| 2021-12-17 | 2021-12-15 | IRWD | IRONWOOD PHARMACEUTICALS INC | Dreyfus Andrew | Dir | A - Grant | $0.00 | +1,431 | 130.1K | +1% | $0 | |
| 2021-09-17 | 2021-09-15 | IRWD | IRONWOOD PHARMACEUTICALS INC | Dreyfus Andrew | Dir | A - Grant | $0.00 | +1,344 | 134.7K | +1% | $0 |
Purchase Sale Sale after option exercise All abbreviations